Randomized trial investigates NK cell receptor function, revealing reduced activity due to self-MHC-I interactions, suggesting adaptive immune implications.
Introduction Activating NK cell receptors are critical for controlling acute murine cytomegalovirus (MCMV) infection, most clearly demonstrated in C57BL/6 mice, where resistance is mediated by the Ly49H receptor through recognition of the viral ligand m157 expressed on infected cells. NK cell—dependent resistance to MCMV is also observed in Ly49H-deficient strains, such as MA/My, where Ly49P and Ly49R can recognize MCMV-infected cells in a class I MHC—dependent manner in vitro. However, the role of these receptors in vivo has not been explored. In addition, these activating receptors may engage self—MHC class I ligands in vivo, yet the physiological relevance of this interaction remains poorly defined. Methods To selectively assess Ly49P function in vivo, we generated Ly49- and MHC class I—deficient mice expressing a single Ly49P receptor on NK cells by knocking in Ly49P cDNA into the Ncr1 locus. Founder mice were then subsequently crossed onto distinct MHC class I backgrounds. Results NK cells from Ly49P-KkDk or Ly49P-KdDd mice exhibited reduced surface expression of Ly49P compared with Ly49P-KbDb mice, suggesting MHC class I—dependent masking of Ly49P. Consistently, Ly49P-KkDk NK cells showed diminished degranulation and IFN-γ production compared with controls following anti-Ly49P or NK1.1 stimulation, indicating a generalized hyporesponsive state to ITAM-associated signaling. This anergic state appeared to be regulated at the level of proximal signaling, as NK cell responsiveness was restored by PMA/ionomycin stimulation, which bypasses early signaling events. Notably, disruption of Ly49P—MHC class I cis interactions by citric acid treatment restored responsiveness of hyporesponsive NK cells to both Ly49P and NK1.1 crosslinking. Conclusion Thus, sustained stimulation of a self-specific activating receptor in vivo induces a hyporesponsive state to stimulation through both cognate and unrelated activating receptors. Funding Source NIH Topic Categories Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
No takes yet. Share an insight, caveat, or question.
Perumal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: